Eterna Therapeutics (ERNA) Fails to deliver data

Key failure to deliver metrics for Eterna Therapeutics:

• Last SEC data release: 2026-01-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last 12 months FTD volume: S$1.49 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Eterna Therapeutics (ERNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Eterna Therapeutics (ERNA) - since 2022

Eterna Therapeutics (ERNA) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Sanofi SNY	S$10.89 M	S$69.64 M	🇫🇷 France
Baxter BAX	S$29.08 M	S$0.10 B	🇺🇸 USA
Omeros Corporation OMER	S$8.63 M	S$18.74 M	🇺🇸 USA
Geron GERN	S$0.3 M	S$4.53 M	🇺🇸 USA
Genetic Technologies GENE	N/A	S$0 M	🇦🇺 Australia
Teva Pharmaceutical Industries TEVA	S$53.08 M	S$87.14 M	🇮🇱 Israel
Bio-Techne TECH	S$9.3 M	S$18.92 M	🇺🇸 USA